Allogeneic administration of human umbilical cord-derived mesenchymal stem/stromal cells for bronchopulmonary dysplasia: preliminary outcomes in four Vietnamese infants.
Liem Thanh NguyenThai T H TrieuHue T H BuiVan T HoangAnh T T NguyenNhung T H TrinhKien T NguyenDuc M HoangPublished in: Journal of translational medicine (2020)
Allo-UC-MSC administration is safe in preterm infants with established BPD. Trial registration This preliminary study was approved by the Vinmec International Hospital Ethics Board (approval number: 88/2019/QĐ-VMEC; retrospectively registered March 12, 2019).
Keyphrases
- umbilical cord
- preterm infants
- mesenchymal stem cells
- bone marrow
- endothelial cells
- stem cell transplantation
- public health
- healthcare
- stem cells
- clinical trial
- study protocol
- low birth weight
- big data
- metabolic syndrome
- type diabetes
- randomized controlled trial
- adipose tissue
- low dose
- high dose
- deep learning
- skeletal muscle
- hematopoietic stem cell
- artificial intelligence